Iovance Biotherapeutics I...

NASDAQ: IOVA · Real-Time Price · USD
2.63
0.18 (7.35%)
At close: Aug 15, 2025, 2:18 PM

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics reported an annual revenue of $164.07M, reflecting a 13698.99% growth. For the quarter ending June 30, 2025, Iovance Biotherapeutics generated $59.95M in revenue.
Revenue (ttm)
164.07M
Revenue Growth
13698.99%
Price / Sales Ratio
13.07
Revenue / Employee
195.79K
Employees
838
Market Cap
953.49M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.